Table of Contents

2019-2024 Global Batten Disease Treatment Market Report (Status and Outlook)

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Batten Disease Treatment Market Size 2014-2024
  • 2.1.2 Batten Disease Treatment Market Size CAGR by Region
• 2.2 Batten Disease Treatment Segment by Type
  • 2.2.1 Occupational Therapies
  • 2.2.2 Physical Therapies
• 2.3 Batten Disease Treatment Market Size by Type
  • 2.3.1 Global Batten Disease Treatment Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Batten Disease Treatment Market Size Growth Rate by Type (2014-2019)
• 2.4 Batten Disease Treatment Segment by Application
  • 2.4.1 Infantile NCL
  • 2.4.2 Late Infantile NCL
  • 2.4.3 Juvenile NCL
  • 2.4.4 Adult NCL
• 2.5 Batten Disease Treatment Market Size by Application
  • 2.5.1 Global Batten Disease Treatment Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Batten Disease Treatment Market Size Growth Rate by Application (2014-2019)

3 Global Batten Disease Treatment by Players

• 3.1 Global Batten Disease Treatment Market Size Market Share by Players
  • 3.1.1 Global Batten Disease Treatment Market Size by Players (2017-2019)
  • 3.1.2 Global Batten Disease Treatment Market Size Market Share by Players (2017-2019)
• 3.2 Global Batten Disease Treatment Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Batten Disease Treatment by Regions

• 4.1 Batten Disease Treatment Market Size by Regions
• 4.2 Americas Batten Disease Treatment Market Size Growth
• 4.3 APAC Batten Disease Treatment Market Size Growth
• 4.4 Europe Batten Disease Treatment Market Size Growth
• 4.5 Middle East & Africa Batten Disease Treatment Market Size Growth

5 Americas

• 5.1 Americas Batten Disease Treatment Market Size by Countries
• 5.2 Americas Batten Disease Treatment Market Size by Type
• 5.3 Americas Batten Disease Treatment Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Batten Disease Treatment Market Size by Countries
• 6.2 APAC Batten Disease Treatment Market Size by Type
• 6.3 APAC Batten Disease Treatment Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Batten Disease Treatment by Countries
• 7.2 Europe Batten Disease Treatment Market Size by Type
• 7.3 Europe Batten Disease Treatment Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Batten Disease Treatment by Countries
• 8.2 Middle East & Africa Batten Disease Treatment Market Size by Type
• 8.3 Middle East & Africa Batten Disease Treatment Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Batten Disease Treatment Market Forecast

• 10.1 Global Batten Disease Treatment Market Size Forecast (2019-2024)
• 10.2 Global Batten Disease Treatment Forecast by Regions
  • 10.2.1 Global Batten Disease Treatment Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Batten Disease Treatment Forecast by Type
• 10.8 Global Batten Disease Treatment Forecast by Application

11 Key Players Analysis

• 11.1 BioMarin Pharmaceuticals
  • 11.1.1 Company Details
  • 11.1.2 Batten Disease Treatment Product Offered
  • 11.1.3 BioMarin Pharmaceuticals Batten Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 BioMarin Pharmaceuticals News
• 11.2 Seneb BioSciences, Inc.
  • 11.2.1 Company Details
  • 11.2.2 Batten Disease Treatment Product Offered
  • 11.2.3 Seneb BioSciences, Inc. Batten Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 Seneb BioSciences, Inc. News
• 11.3 ReGenX Biosciences LLC
  • 11.3.1 Company Details
  • 11.3.2 Batten Disease Treatment Product Offered
  • 11.3.3 ReGenX Biosciences LLC Batten Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 ReGenX Biosciences LLC News
• 11.4 Amicus Therapeutics
  • 11.4.1 Company Details
  • 11.4.2 Batten Disease Treatment Product Offered
  • 11.4.3 Amicus Therapeutics Batten Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 Amicus Therapeutics News
• 11.5 Ionis Pharmaceuticals, Inc.
  • 11.5.1 Company Details
  • 11.5.2 Batten Disease Treatment Product Offered
  • 11.5.3 Ionis Pharmaceuticals, Inc. Batten Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 Ionis Pharmaceuticals, Inc. News
• 11.6 Celenex, Inc.
  • 11.6.1 Company Details
  • 11.6.2 Batten Disease Treatment Product Offered
  • 11.6.3 Celenex, Inc. Batten Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.6.4 Main Business Overview
  • 11.6.5 Celenex, Inc. News

...

12 Research Findings and Conclusion

Batten disease is inherited disorder of the nervous system which begins in childhood.It is also called as neuronal ceroid lipofuscinoses (or NCLs). Batten Disease Treatment is the treatment of this type of disease.

According to this study, over the next five years the Batten Disease Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Batten Disease Treatment business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Batten Disease Treatment market by product type, application, key companies and key regions.

This study considers the Batten Disease Treatment value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Occupational Therapies
Physical Therapies
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Infantile NCL
Late Infantile NCL
Juvenile NCL
Adult NCL

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
BioMarin Pharmaceuticals
Seneb BioSciences, Inc.
ReGenX Biosciences LLC
Amicus Therapeutics
Ionis Pharmaceuticals, Inc.
Celenex, Inc.
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Batten Disease Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Batten Disease Treatment market by identifying its various subsegments.
Focuses on the key global Batten Disease Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Batten Disease Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Batten Disease Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.